Biomerica, Inc.
BMRA
$2.71
-$0.08-2.87%
NASDAQ
| 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.88M | 5.31M | 5.68M | 5.58M | 5.51M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.88M | 5.31M | 5.68M | 5.58M | 5.51M |
| Cost of Revenue | 4.25M | 4.81M | 4.91M | 4.98M | 5.02M |
| Gross Profit | 636.00K | 501.00K | 765.00K | 597.00K | 485.00K |
| SG&A Expenses | 4.58M | 4.61M | 4.83M | 5.32M | 5.67M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.77M | 10.45M | 10.78M | 11.47M | 12.01M |
| Operating Income | -4.89M | -5.14M | -5.10M | -5.89M | -6.50M |
| Income Before Tax | -3.65M | -4.97M | -4.85M | -5.59M | -6.14M |
| Income Tax Expenses | 1.00K | 2.00K | 4.00K | 12.00K | 23.00K |
| Earnings from Continuing Operations | -3.66 | -4.97 | -4.85 | -5.61 | -6.16 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.66M | -4.97M | -4.85M | -5.61M | -6.16M |
| EBIT | -4.89M | -5.14M | -5.10M | -5.89M | -6.50M |
| EBITDA | -4.80M | -5.05M | -5.01M | -5.80M | -6.42M |
| EPS Basic | -1.63 | -2.25 | -2.23 | -2.66 | -2.93 |
| Normalized Basic EPS | -1.02 | -1.41 | -1.39 | -1.66 | -1.82 |
| EPS Diluted | -1.69 | -2.32 | -2.27 | -2.70 | -2.94 |
| Normalized Diluted EPS | -1.02 | -1.41 | -1.39 | -1.66 | -1.82 |
| Average Basic Shares Outstanding | 9.38M | 8.85M | 8.75M | 8.45M | 8.41M |
| Average Diluted Shares Outstanding | 9.38M | 8.85M | 8.75M | 8.45M | 8.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |